Kufvita Kraiss & Friz (Oxygen)

Oxygen, the active ingredient in Kufvita Kraiss & Friz, is a medical gas presented as a medical gas for inhalation use. It supplies supplemental oxygen to increase arterial oxygen tension and improve tissue oxygenation, and is employed in the management of hypoxemia, respiratory distress, and carbon monoxide poisoning.

GNH USA supplies Kufvita Kraiss & Friz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to EU quality standards and provides reliable logistics for clinical and emergency care settings.

Kufvita Kraiss & Friz (oxygen) is used in oxygen therapy to address conditions characterized by low blood oxygen levels.

- Hypoxemia: restores adequate arterial oxygen saturation to support vital organ function. - Respiratory distress: improves oxygen delivery to alleviate breathing difficulty. - Carbon monoxide poisoning: displaces carbon monoxide from hemoglobin and accelerates its elimination.

Administration of supplemental oxygen may be associated with adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nasal or throat dryness: irritation of the mucous membranes due to dry gas flow. - Headache: mild to moderate headache may develop during therapy. - Cough or mild bronchospasm: airway irritation can provoke coughing.

Serious or Rare Side Effects: - Pulmonary oxygen toxicity: prolonged exposure to high concentrations can damage lung tissue. - Central nervous system toxicity: seizures may occur with very high oxygen levels. - Fire hazard: oxygen supports combustion, increasing fire risk in the treatment environment.

When using supplemental oxygen, clinicians should follow specific safety and monitoring guidelines. - Assess patient oxygen saturation before initiating therapy: use pulse oximetry to determine need. - Monitor oxygen flow rate and concentration: adjust to maintain target SpO₂. - Avoid excessive oxygen in COPD patients: risk of CO₂ retention. - Use fire‑safe equipment and keep away from open flames: oxygen supports combustion. - Educate patients on proper nasal cannula or mask use: ensure correct fit. - Store at ambient temperature: keep cylinders in a well‑ventilated, dry area, protected from heat and direct sunlight.

Oxygen can interact with other agents, influencing safety and efficacy.

Major Interactions (Avoid): - Nitrous oxide: concurrent use can increase fire risk and alter oxygen concentration. - Flammable anesthetic agents: oxygen enhances combustibility, avoid simultaneous administration. - High‑concentration oxygen with certain chemotherapeutic agents: may increase oxidative stress (theoretical).

Moderate Interactions (Monitor Closely): - Sedatives and opioids: may depress respiratory drive, monitor oxygenation closely. - Bronchodilators: may alter airway resistance, adjust flow as needed.